RAPH1 and cancer: Using mass spectrometry in cancer cells lines, Liu et al. identified RAPH1-v3, a splice variant of RAPH1 that localises to the nucleus and is enriched in radioresistant TNBC cells, as a FOXQ1 interactor [78].